Rathmell WK - Search Results

1

Belzutifan for Renal Cell Carcinoma in von Hippel-Lindau Disease.

Jonasch E, Donskov F, Iliopoulos O, Rathmell WK, Narayan VK, Maughan BL, Oudard S, Else T, Maranchie JK, Welsh SJ, Thamake S, Park EK, Perini RF, Linehan WM, Srinivasan R; MK-6482-004 Investigators. Jonasch E, et al. Among authors: rathmell wk. N Engl J Med. 2021 Nov 25;385(22):2036-2046. doi: 10.1056/NEJMoa2103425. N Engl J Med. 2021. PMID: 34818478 Free PMC article. Clinical Trial.

2

HIF transcription factor expression and induction of hypoxic response genes in a retroperitoneal angiosarcoma.

Rathmell WK, Acs G, Simon MC, Vaughn DJ. Rathmell WK, et al. Anticancer Res. 2004 Jan-Feb;24(1):167-9. Anticancer Res. 2004. PMID: 15015593 Free article.

3

Phase II trial of 5-fluorouracil and leucovorin in combination with interferon-alpha and interleukin-2 for advanced renal cell cancer.

Rathmell WK, Malkowicz SB, Holroyde C, Luginbuhl W, Vaughn DJ. Rathmell WK, et al. Am J Clin Oncol. 2004 Apr;27(2):109-12. doi: 10.1097/01.coc.0000046599.52805.00. Am J Clin Oncol. 2004. PMID: 15057147 Clinical Trial.

4

In vitro and in vivo models analyzing von Hippel-Lindau disease-specific mutations.

Rathmell WK, Hickey MM, Bezman NA, Chmielecki CA, Carraway NC, Simon MC. Rathmell WK, et al. Cancer Res. 2004 Dec 1;64(23):8595-603. doi: 10.1158/0008-5472.CAN-04-1430. Cancer Res. 2004. PMID: 15574766

5

HIF-alpha effects on c-Myc distinguish two subtypes of sporadic VHL-deficient clear cell renal carcinoma.

Gordan JD, Lal P, Dondeti VR, Letrero R, Parekh KN, Oquendo CE, Greenberg RA, Flaherty KT, Rathmell WK, Keith B, Simon MC, Nathanson KL. Gordan JD, et al. Among authors: rathmell wk. Cancer Cell. 2008 Dec 9;14(6):435-46. doi: 10.1016/j.ccr.2008.10.016. Cancer Cell. 2008. PMID: 19061835 Free PMC article.

6

State of the science: an update on renal cell carcinoma.

Jonasch E, Futreal PA, Davis IJ, Bailey ST, Kim WY, Brugarolas J, Giaccia AJ, Kurban G, Pause A, Frydman J, Zurita AJ, Rini BI, Sharma P, Atkins MB, Walker CL, Rathmell WK. Jonasch E, et al. Among authors: rathmell wk. Mol Cancer Res. 2012 Jul;10(7):859-80. doi: 10.1158/1541-7786.MCR-12-0117. Epub 2012 May 25. Mol Cancer Res. 2012. PMID: 22638109 Free PMC article. Review.

7

In vivo HIF-mediated reductive carboxylation is regulated by citrate levels and sensitizes VHL-deficient cells to glutamine deprivation.

Gameiro PA, Yang J, Metelo AM, Pérez-Carro R, Baker R, Wang Z, Arreola A, Rathmell WK, Olumi A, López-Larrubia P, Stephanopoulos G, Iliopoulos O. Gameiro PA, et al. Among authors: rathmell wk. Cell Metab. 2013 Mar 5;17(3):372-85. doi: 10.1016/j.cmet.2013.02.002. Cell Metab. 2013. PMID: 23473032 Free PMC article.

8

The molecular biology of renal cell carcinoma.

Keefe SM, Nathanson KL, Rathmell WK. Keefe SM, et al. Among authors: rathmell wk. Semin Oncol. 2013 Aug;40(4):421-8. doi: 10.1053/j.seminoncol.2013.05.006. Semin Oncol. 2013. PMID: 23972705 Review.

9

ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma.

Brooks SA, Brannon AR, Parker JS, Fisher JC, Sen O, Kattan MW, Hakimi AA, Hsieh JJ, Choueiri TK, Tamboli P, Maranchie JK, Hinds P, Miller CR, Nielsen ME, Rathmell WK. Brooks SA, et al. Among authors: rathmell wk. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035. Epub 2014 Feb 25. Eur Urol. 2014. PMID: 24613583 Free PMC article.

10

Renal cell carcinoma.

Jonasch E, Gao J, Rathmell WK. Jonasch E, et al. Among authors: rathmell wk. BMJ. 2014 Nov 10;349:g4797. doi: 10.1136/bmj.g4797. BMJ. 2014. PMID: 25385470 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

311 results

Search Page

Filters